NYSE
ELV
Last Price
US $386.73
KEY FIGURES
MKT CAP
$85.8B
EPS
TTM
$23.78
PEG
TTM
N/M
P/E
TTM
16.81x
P/S
TTM
0.43x
YIELD
1.74%
GROWTH
Revenue Y/Y
10.32%
(FY vs FY)
EBITDA Y/Y
Cash Flow (DCF)
Fair Value
Market $386.73
—
Default assumptions
EBITDA Multiple
Fair Value
Market $386.73
-48.61%
Default assumptions
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Elevance Health Inc. cash flow to debt ratio of 12.91% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
Elevance Health Inc.'s free cash flow has decreased -30.27% from $4.55G last year to $3.17G, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
Elevance Health Inc.'s debt to equity ratio is 0.73, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial stability - Healthy debt to equity ratio development.
Elevance Health Inc.'s debt has decreased relative to shareholder equity from 0.79 last year to 0.73 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
Elevance Health Inc. has a net debt to EBITDA ratio of 2.46x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Elevance Health Inc.'s interest coverage ratio of 5.39 indicates that earnings with good margin can cover interest payments on company debt
Financial risk - Profit margin growth.
Elevance Health Inc.'s profit margin has decreased (-22.65%) in the last year from 3.38% to 2.62%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
Elevance Health Inc.'s short-term assets of $24.73G exceed its short-term liabilities of $19.96G
Decreasing performance - ROA.
Elevance Health Inc.'s return on assets of 4.17% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Elevance Health Inc.'s return on equity of 11.95%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Elevance Health Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Increasing performance - Earnings stability.
Elevance Health Inc. had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Elevance Health Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Elevance Health Inc. has a free cash flow yield of 3.70%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Decreasing performance - Healthy earnings growth.
Elevance Health Inc.'s yearly earnings has decreased -5.32% since last year from $5.98G to $5.66G, signaling decreasing performance
Increasing performance - Healthy revenue growth.
Elevance Health Inc.'s yearly revenue has increased 12.37% since last year from $176.81G to $198.69G, signaling increasing performance
Increasing performance - ROIC.
ROIC 7.91% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.
Increasing performance - 3-year revenue CAGR.
Elevance Health Inc.'s 3-year revenue CAGR of 8.34% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Elevance Health Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Elevance Health Inc. had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Elevance Health Inc. has insufficient data to evaluate this check.
Undervalued - Earnings yield.
Elevance Health Inc. has an earnings yield of 6.02%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
Elevance Health Inc. is overvalued relative to its fair value price of 198.74 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Elevance Health Inc. has an EV/EBITDA ratio of 12.11x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
Elevance Health Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Elevance Health Inc. has a price-to-book ratio of 1.98x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Elevance Health Inc. has a price-to-sales ratio of 0.43x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
11.95%
Return on equity
ROIC: 7.91%
Valuation History
16.8X
Price to Earnings
EV/EBITDA: 12.1X
Cash flow
Profit margin
3.39%
(FY vs FY)
Cash flow Y/Y
-19.97%
(FY vs FY)
EARNINGS FV (GRAHAM)
Fair Value
Market $386.73
131.48%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.